Hematopoietic cell transplantation using plasma and DMSO without HES, with non-programmed freezing by immersion in a methanol bath:: results in 213 cases

被引:18
作者
Hernández-Navarro, F
Ojeda, E
Arrieta, R
Ríos-Rull, P
García-Bustos, J
Quevedo, E
Hernández, MPM
Jiménez-Yuste, V
Rodríguez-Luaces, M
López, RM
García-Miguel, P
Martínez, A
Sastre, A
Calero, F
Gómez-Pastrana, F
Martínez, B
机构
[1] Hosp La Paz, Serv Hematol & Hemoterapia, Madrid 28046, Spain
[2] Hosp La Paz, Serv Oncohematol Pediat, Madrid 28046, Spain
[3] Hosp La Paz, Serv Ginecol Oncol, Madrid 28046, Spain
[4] Hosp Virgen Salud, Med Oncol Serv, Toledo, Spain
关键词
hematopoietic cell transplantation; cryopreservation; plasma and DMSO; non-programmed freezing; methanol;
D O I
10.1038/sj.bmt.1701125
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
A simplified cryopreservation method for bone marrow (BM) and peripheral blood progenitor cells (PBPC) was utilized in hematopoietic cell transplantation of 213 patients with hematological or solid neoplasms after ablative chemotherapy (187 with peripheral blood progenitor cells and 26 with bone marrow), Cells were cryopreserved, after addition of autologous fresh plasma with DMSO, without HES, by freezing to -80 degrees C in a methanol bath and non-programmed freezer, For the patients autotransplanted with PBPC, the median period necessary for recovery of more than 0.5 x 10(9)/l granulocytes was 11 days (range 6-44), and 15 (8-204) days were required to obtain more than 20 x 10(9)/l platelets, For the patients autotransplanted with BM, the median period necessary to recover >0.5 x 10(9)/l granulocytes was 12 days (range 9-33), and 24 (12-57) days to obtain more than 20 x 10(9)/l platelets, These results support this method as being very effective in achieving high-quality cryopreservation, The procedure, which uses a non-programmed freezer, simplifies and reduces enormously the cost of the technical measures currently in use, enabling its adoption in almost any clinical oncological institution.
引用
收藏
页码:511 / 517
页数:7
相关论文
共 24 条
[1]   AUTOMATED PROCESSING OF HUMAN BONE-MARROW CAN RESULT IN A POPULATION OF MONONUCLEAR-CELLS CAPABLE OF ACHIEVING ENGRAFTMENT FOLLOWING TRANSPLANTATION [J].
AREMAN, EM ;
CULLIS, H ;
SPITZER, T ;
SACHER, RA .
TRANSFUSION, 1991, 31 (08) :724-730
[2]  
CLARK J, 1991, BONE MARROW TRANSPL, V7, P121
[3]  
CLIFT RA, 1990, BLOOD, V76, P1867
[4]  
DINI G, 1989, BONE MARROW TRANSPL, V4, P42
[5]   PROLONGED IMPAIRMENT OF HEMATOPOIESIS AFTER HIGH-DOSE THERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION [J].
DOMENECH, J ;
LINASSIER, C ;
GIHANA, E ;
DAYAN, A ;
TRUGLIO, D ;
BOUT, M ;
PETITDIDIER, C ;
DELAIN, M ;
PETIT, A ;
BREMOND, JL ;
DESBOIS, I ;
LAMAGNERE, JP ;
COLOMBAT, P ;
BINET, C .
BLOOD, 1995, 85 (11) :3320-3327
[6]   A PHASE-I-II STUDY OF CYCLOPHOSPHAMIDE, THIOTEPA, AND CARBOPLATIN WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN SOLID TUMOR PATIENTS [J].
EDER, JP ;
ELIAS, A ;
SHEA, TC ;
SCHRYBER, SM ;
TEICHER, BA ;
HUNT, M ;
BURKE, J ;
SIEGEL, R ;
SCHNIPPER, LE ;
FREI, E ;
ANTMAN, K .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (07) :1239-1245
[7]  
Gorin NC, 1992, BONE MARROW STEM CEL, P292
[8]  
Gorlin J, 1996, J Infus Chemother, V6, P23
[9]  
HERNANDEZNAVARRO F, 1995, BONE MARROW TRANSPL, V16, P71
[10]  
HOHAUS S, 1993, EXP HEMATOL, V21, P508